Editors' Pick
Debate: Do Physicians Rate the Risk of Disabling MS Less Than the Risk of Effective Treatment?
MS prescribing depends on balancing benefit against hard-to-assess risk. At the recent World Congress of Neurology in Vienna, two experts in MS debated whether physicians rate the risk of disabling MS less than the risk of effective treatment. The debate centered on how clinicians and patients perceive risk and how decision-making must be done collaboratively.
How much risk is appropriate in the treatment of multiple sclerosis? For that matter, which risks should we focus on...
People
Survey Finds “MSer” to Be Patients' Preferred Descriptor
A convenience survey of people with MS found "MSer" to be the preferred descriptor for a person with the disease
What is the preferred way for clinicians and researchers to refer to people who...
People
Editors' Pick
ECTRIMS 2013 Day 4
The European Committee for Treatment and Research in Multiple Sclerosis is meeting in Copenhagen, Denmark 2-5 October 2013.
Meetings
Papers: 27 Sep 2013 - 4 Oct 2013
ECTRIMS 2013 Day 3
The European Committee for Treatment and Research in Multiple Sclerosis is meeting in Copenhagen, Denmark 2-5 October 2013.
Meetings
ECTRIMS 2013 Day 2
The European Committee for Treatment and Research in Multiple Sclerosis is meeting in Copenhagen, Denmark 2-5 October 2013. Multiple Sclerosis Discovery Forum staffers Bob Finn and Carol Cruzan Morton will be live tweeting from the event.
Meetings
ECTRIMS 2013 Day 1
The European Committee for Treatment and Research in Multiple Sclerosis is meeting in Copenhagen, Denmark 2-5 October 2013. Multiple Sclerosis Discovery Forum staffers Bob Finn and Carol Cruzan Morton will be live tweeting from the event. Follow their tweets here or at @MSDForum.
Meetings
Editors' Pick
Pages
